USPTO serial 90524778
TRICORDER
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- YONTEF, DAVID ERIC
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TRICORDER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mallory Levitt
Mallory Levitt Paramount Global Law1515 BroadwayNEW YORK, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices, namely, point of care and handheld medical diagnostic instruments for analyzing body fluids for the presence of drugs, proteins and other substances and also featuring technology therein for wirelessly transferring medical data; medical measuring apparatus, namely, medical diagnostic instruments for the analysis of body fluids and tissue; medical measuring apparatus, namely, medical diagnostic test cartridges for analyzing body fluids for the presence of substances in the body used during medical therapies; apparatus for blood analysis; apparatus for taking blood samples; blood testing apparatus; apparatus for urine analysis for medical diagnostics, monitoring and reporting; medical diagnostic instruments for analyzing biological tissue and body fluids; containers especially made for processing blood samples for medical purposes; devices for measuring blood sugar; electronic medical diagnostic apparatus, namely, analytic biosensors for detecting a wide variety of infectious diseases; health monitoring devices for medical purposes, namely, personal medical blood pressure monitors, pulse rate monitors, blood oxygen monitors, blood glucose monitors, blood composition monitors, cholesterol meters and electronic temperature monitors, all for monitoring a wide variety of physical conditions and diseases; medical diagnostic apparatus, namely, blood pressure monitors, pulse rate monitors, blood oxygen monitors, blood glucose monitors, blood composition monitors, cholesterol meters and electronic temperature monitors, all for diagnosing a wide variety of physical conditions and diseases; medical apparatus and instruments for monitoring blood properties; medical devices for obtaining body fluid samples; medical apparatus and instruments for measuring a wide variety of physiological conditions and diseases, namely, individualized and electronic monitors for measuring biochemical, hematological, neurological, pulmonary, muscular and cardiac activity; home and portable medical apparatus and instruments for measuring a wide variety of physiological conditions and diseases, namely, individualized and electronic monitors for measuring biochemical, hematological, neurological, pulmonary, muscular and cardiac activity; mobile electronic devices for medical testing, monitoring and reporting purposes, namely, medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus and computer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual, all for medical and healthcare purposes for individualized medicine and healthcare | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 1, 2025 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| Apr 1, 2025 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Mar 31, 2025 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 17, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 17, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 17, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jun 17, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 21, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 19, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Dec 19, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Dec 19, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 23, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 21, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jun 21, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jun 21, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 20, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 16, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Dec 16, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 16, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 20, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 20, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 20, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 25, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 25, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 25, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 25, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 21, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 26, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 26, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 6, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 20, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 20, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 8, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 15, 2021 | NWAP | NEW APPLICATION ENTERED | — |